Livanova Plc share price today
(NASDAQ: LIVN)

Name: Livanova Plc Share Price Today (NASDAQ: LIVN) - Livanova Plc Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Livanova Plc share price is $48.82 & ₹4,222.44 as on 24 Jan 2025, 2.30 'hrs' IST

$48.82

▲

0.17

(0.35%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Livanova Plc share price in Dollar and Rupees. Guide to invest in Livanova Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Livanova Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Livanova Plc share price movements

Today's Low: $48.35
Today's High: $49.23
$48.82
0.97%
Downside
Day's Volatility :1.79%
Upside
0.82%
52 Weeks Low: $43.15
52 Weeks High: $64.48
$48.82
11.61%
Downside
52 Weeks Volatility :33.07%
Upside
24.28%

Livanova Plc Returns

Period	Livanova Plc	Sector (Health Care)	Index (Russel 2000)
3 Months	-8.21%	-5.5%	0.0%
6 Months	-9.25%	-4.3%	0.0%
1 Year	-2.58%	1.6%	0.0%
3 Years	-36.59%	9.8%	-11.0%

Livanova Plc Key Statistics

in dollars & INR

Previous Close	$48.65
Open	$48.62
Today's High	$49.225
Today's Low	$48.345
Market Capitalization	$2.7B
Today's Volume	$403.6K
52 Week High	$64.475
52 Week Low	$43.15
Revenue TTM	$1.2B
EBITDA	$212.6M
Earnings Per Share (EPS)	$0.43
PE Ratio	114.44
Profit Margin	1.91%
Quarterly Earnings Growth YOY	14.0%
Return On Equity TTM	1.87%

How to invest in Livanova Plc Stock (LIVN) from India?

It is very easy for Indian residents to invest directly in Livanova Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Livanova Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Livanova Plc or LIVN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Livanova Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Livanova Plc shares which would translate to 0.018 fractional shares of Livanova Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Livanova Plc, in just a few clicks!

Returns in Livanova Plc for Indian investors in Rupees

Investment Value

₹1,00,000

Livanova Plc investment value today

Current value as on today

₹1,01,812

Returns

₹1,812

(+1.81%)

Returns from Livanova Plc Stock

₹2,243 (-2.24%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Livanova Plc

-50%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Livanova Plc on INDmoney from India has reduced in the last 30 days as on Jan 24, 2025. -50% less investors are searching Livanova Plc in the last 30 days versus the previous period.

Global Institutional Holdings in Livanova Plc

BlackRock Inc
12.96%
PRIMECAP Management Company
10.36%
Millennium Management LLC
5.45%
Point72 Asset Management, L.P.
3.85%
Vanguard Group Inc
3.84%
State Street Corp
3.76%

Analyst Recommendation on Livanova Plc

Buy

73%Buy

26%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Livanova Plc(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Livanova Plc

What analysts predicted

Upside of 40.96%

Target:

$68.82

Current:

$48.82

Insights on Livanova Plc

Price Movement
In the last 3 months, LIVN stock has moved down by -8.2%
Decreasing Revenue
Revenue is down for the last 2 quarters, 318.57M → 318.12M (in $), with an average decrease of 0.1% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -41.94M → 32.95M (in $), with an average increase of 203.6% per quarter
LIVN vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 65.5% return, outperforming this stock by 69.6%
LIVN vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 133.4% return, outperforming this stock by 171.3%
Price to Sales
ForLIVN every $1 of sales, investors are willing to pay $2.1, whereas for Boston Scientific Corp., the investors are paying $9.3 for every $1 of sales.

Livanova Plc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.1B	↑ 9.35%
Net Income	$-189.4M	↑ 654.58%
Net Profit Margin	-17.11%	↓ 14.63%

	FY19	Y/Y Change
Revenue	$1.1B	↓ 2.06%
Net Income	$-155.5M	↓ 17.9%
Net Profit Margin	-14.34%	↑ 2.77%

	FY20	Y/Y Change
Revenue	$934.2M	↓ 13.84%
Net Income	$-343.3M	↑ 120.77%
Net Profit Margin	-36.75%	↓ 22.41%

	FY21	Y/Y Change
Revenue	$1.0B	↑ 10.83%
Net Income	$-135.7M	↓ 60.47%
Net Profit Margin	-13.11%	↑ 23.64%

	FY22	Y/Y Change
Revenue	$1.0B	↓ 1.31%
Net Income	$-86.2M	↓ 36.48%
Net Profit Margin	-8.44%	↑ 4.67%

	FY23	Y/Y Change
Revenue	$1.2B	↑ 12.89%
Net Income	$17.5M	↓ 120.35%
Net Profit Margin	1.52%	↑ 9.96%

	Q2 FY23	Q/Q Change
Revenue	$293.9M	↑ 11.58%
Net Income	$1.2M	↓ 84.33%
Net Profit Margin	0.39%	↓ 2.41%

	Q3 FY23	Q/Q Change
Revenue	$286.1M	↓ 2.65%
Net Income	$-7.3M	↓ 732.03%
Net Profit Margin	-2.55%	↓ 2.94%

	Q4 FY23	Q/Q Change
Revenue	$310.1M	↑ 8.39%
Net Income	$16.3M	↓ 323.82%
Net Profit Margin	5.27%	↑ 7.82%

	Q1 FY24	Q/Q Change
Revenue	$294.9M	↓ 4.9%
Net Income	$-41.9M	↓ 356.7%
Net Profit Margin	-14.22%	↓ 19.49%

	Q2 FY24	Q/Q Change
Revenue	$318.6M	↑ 8.02%
Net Income	$16.3M	↓ 138.94%
Net Profit Margin	5.13%	↑ 19.35%

	Q3 FY24	Q/Q Change
Revenue	$318.1M	↓ 0.14%
Net Income	$33.0M	↑ 101.76%
Net Profit Margin	10.36%	↑ 5.23%

	FY18	Y/Y Change
Profit	$734.5M	↑ 12.72%

	FY19	Y/Y Change
Profit	$744.8M	↑ 1.4%

	FY20	Y/Y Change
Profit	$618.2M	↓ 17.0%

	FY21	Y/Y Change
Profit	$706.0M	↑ 14.2%

	FY22	Y/Y Change
Profit	$707.2M	↑ 0.17%

	FY23	Y/Y Change
Profit	$771.3M	↑ 9.06%

	Q2 FY23	Q/Q Change
Profit	$205.2M	↑ 17.86%

	Q3 FY23	Q/Q Change
Profit	$201.8M	↓ 1.66%

	Q4 FY23	Q/Q Change
Profit	$190.2M	↓ 5.75%

	Q1 FY24	Q/Q Change
Profit	$210.6M	↑ 10.72%

	Q2 FY24	Q/Q Change
Profit	$220.4M	↑ 4.64%

	Q3 FY24	Q/Q Change
Profit	$225.3M	↑ 2.22%

	FY18	Y/Y Change
Operating Cash Flow	$120.5M	↑ 31.98%
Investing Cash Flow	$-120.6M	↑ 128.09%
Financing Cash Flow	$-42.3M	↓ 474.34%

	FY19	Y/Y Change
Operating Cash Flow	$-91.1M	↓ 175.6%
Investing Cash Flow	$-41.3M	↓ 65.75%
Financing Cash Flow	$146.6M	↓ 446.57%

	FY20	Y/Y Change
Operating Cash Flow	$-79.4M	↓ 12.84%
Investing Cash Flow	$-41.8M	↑ 1.34%
Financing Cash Flow	$310.8M	↑ 112.01%

	FY21	Y/Y Change
Operating Cash Flow	$102.5M	↓ 229.09%
Investing Cash Flow	$36.9M	↓ 188.18%
Financing Cash Flow	$-181.5M	↓ 158.4%

	FY22	Y/Y Change
Operating Cash Flow	$69.9M	↓ 31.8%
Investing Cash Flow	$-38.4M	↓ 204.1%
Financing Cash Flow	$280.1M	↓ 254.33%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-18.0M	↓ 186.54%
Investing Cash Flow	$-6.7M	↓ 42.05%
Financing Cash Flow	$36.0M	↓ 792.31%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$18.2M	↓ 201.11%
Investing Cash Flow	$-10.1M	↑ 51.07%
Financing Cash Flow	$-4.3M	↓ 111.94%

Livanova Plc Technicals Summary

Sell

Neutral

Buy

Livanova Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Livanova Plc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Livanova Plc	3.38%	-9.25%	-2.58%	-36.59%	-30.19%
Medtronic Plc	7.73%	11.61%	2.39%	-15.68%	-26.33%
Edwards Lifesciences Corp.	-8.41%	10.69%	-6.13%	-36.94%	-9.52%
Boston Scientific Corp.	10.15%	33.89%	64.9%	135.97%	135.19%
Stryker Corporation	5.32%	17.73%	25.19%	56.65%	81.96%
Abbott Laboratories	2.63%	11.92%	4.74%	-4.45%	31.47%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Livanova Plc	114.44	114.44	0.46	3.37	0.02	0.04	NA	24.13
Medtronic Plc	27.03	27.03	1.5	5.46	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.66	26.66	6.43	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	83.4	83.4	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	42.47	42.47	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.45	34.45	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Livanova Plc	Buy	$2.7B	-30.19%	114.44	1.91%
Medtronic Plc	Buy	$113.3B	-26.33%	27.03	12.06%
Edwards Lifesciences Corp.	Buy	$40.7B	-9.52%	26.66	65.86%
Boston Scientific Corp.	Buy	$148.7B	135.19%	83.4	11.26%
Stryker Corporation	Buy	$150.9B	81.96%	42.47	16.34%
Abbott Laboratories	Buy	$202.6B	31.47%	34.45	13.99%

About Livanova Plc

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Organization	Livanova Plc
Employees	2900
CEO	Mr. Alex Shvartsburg C.M.A.
Industry	Health Technology

Management People of Livanova Plc

Name	Title
Mr. Alex Shvartsburg C.M.A.	Chief Financial Officer
Mr. Michael D. Hutchinson	Senior VP, Chief Legal Officer & Company Secretary
Mr. Vladimir A. Makatsaria	CEO & Director
Ms. Lindsey Little	Senior Director of Investor Relations
Deanna Wilke	Vice President of Corporate Communications
Mr. Philip Kowalczyk	Chief Strategy & Corporate Development Officer
Ms. Natalia Kozmina	Chief Human Resources Officer
Mr. Paul R. Buckman	President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement
Ms. Stephanie Bolton	President of Global Epilepsy
Ahmet Tezel Ph.D.	Chief Innovation Officer

Important FAQs about investing in Livanova Plc (LIVN) from India :

What is Livanova Plc share price today?

Livanova Plc share price today stands at $48.82, Open: $48.62 ; Previous Close: $48.65 ; High: $49.23 ; Low: $48.35 ; 52 Week High: $64.48 ; 52 Week Low: $43.15. The stock opens at $48.62, after a previous close of $48.65. The stock reached a daily high of $49.23 and a low of $48.35, with a 52-week high of $64.48 and a 52-week low of $43.15.

Can Indians buy Livanova Plc shares?

Yes, Indians can invest in the Livanova Plc (LIVN) from India.

With INDmoney, you can buy Livanova Plc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Livanova Plc at zero transaction cost.

How can I buy Livanova Plc shares from India?

It is very easy to buy Livanova Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Livanova Plc be purchased?

Yes, you can buy fractional shares of Livanova Plc with INDmoney app.

What are the documents required to start investing in Livanova Plc stocks?

To start investing in Livanova Plc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.